Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: Evaluation by in vitro probe acylcarnitine assay
Authors:
- Seiji YamaguchiSYSeiji Yamaguchi
- Hong LiHLHong Li
- Jamiyan PurevsurenJPJamiyan Purevsuren
- Kenji YamadaKYKenji Yamada
- Midori FuruiMFMidori Furui
- Tomoo TakahashiTTTomoo Takahashi
- Yuichi MushimotoYMYuichi Mushimoto
- Hironori KobayashiHKHironori Kobayashi
- Yuki HasegawaYHYuki Hasegawa
- Takeshi TaketaniTTTakeshi Taketani
- Toshiyuki FukaoTFToshiyuki Fukao
- Seiji FukudaSFSeiji Fukuda
- 1 September 2012
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 107 (1-2) , 87-91
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, Culture, and Sports
- Ministry of Health, Labour and Welfare (S.Y.), of Japan
This publication has 22 references indexed in Scilit:
- Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblastsHuman Molecular Genetics, 2011
- Disorders of muscle lipid metabolism: Diagnostic and therapeutic challengesNeuromuscular Disorders, 2010
- Pathophysiology of fatty acid oxidation disordersJournal of Inherited Metabolic Disease, 2009
- Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 YearsPediatrics, 2009
- Effect of heat stress and bezafibrate on mitochondrial β-oxidation: Comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assayBrain and Development, 2009
- Management and outcome in 75 individuals with long‐chain fatty acid oxidation defects: results from a workshopJournal of Inherited Metabolic Disease, 2009
- Genetic Basis for Correction of Very-Long-Chain Acyl–Coenzyme A Dehydrogenase Deficiency by Bezafibrate in Patient Fibroblasts: Toward a Genotype-Based TherapyThe American Journal of Human Genetics, 2007
- Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid β-oxidation defects: phenotype/metabolite correlationsMolecular Genetics and Metabolism, 2002
- Fatty Acid Oxidation DisordersAnnual Review of Physiology, 2002
- Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)Journal of Biological Chemistry, 1998